French-Canadian scientist Michel Sadelain and American immunologist Carl June awarded the Breakthrough Prize for pioneering immune cell cancer therapy.

The Breakthrough Prize, with a $3 million award, surpasses the Nobel Prize in monetary value, highlighting its significance in the scientific community.

Sadelain's work led to CAR-T therapy, a groundbreaking treatment that has shown high efficacy against certain blood cancers.

The treatment has transformed the outlook for patients with previously untreatable forms of cancer, offering new hope and life.

Challenges remain in making the therapy more affordable, though it is currently covered by insurance.

The awards ceremony recognized other scientific achievements, including advancements in cystic fibrosis and Parkinson's disease research.

Sadelain aims to expand CAR-T therapy to additional cancer types, indicating ongoing efforts to broaden the impact of the treatment.

The event, which celebrates scientific innovation, was held at the Oscars museum in Los Angeles and attended by notable figures from technology and entertainment.